UP
PGR
CVS

Roger N. Farah

Known title: DirectorCIK: 0001112072

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 6, 2026

Wheels Up faces sector cash‑burn concerns after recent analysis. A recent Seeking Alpha piece noted that cash burn in the aviation sector is outpacing the software revenue story for Surf Air Mobility. The observation highlights broader financial pressures that could also affect Wheels Up, which operates a similar business model. Investors may watch how the company manages its expenses in this environment.

this person other insiders at UP

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Progressive Q3 Results Show Strong Underwriting, Slower Profit Growth. Progressive's Q3 earnings highlighted robust underwriting, but profit growth slowed compared to prior periods. In response, several analysts trimmed their price targets, with Wells Fargo cutting to $196 and Keefe, Bruyette & Woods to $246. The stock sits near a key support level of $196.44, a level that has been tested ten times in recent trading.

this person other insiders at PGR

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status. CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.

this person other insiders at CVS

Transaction History

UP▲ Buy$0
PGR▲ Buy$0
PGR▼ Sell$0
CVS▼ Sell$783K
PGR▲ Buy$0
PGR▼ Sell$0
CVS▲ Buy$3.0M
PGR▼ Sell$1.1M
PGR▼ Sell$0
PGR▲ Buy$0
PGR▼ Sell$0
PGR▲ Buy$0
PGR▼ Sell$0
PGR▲ Buy$0
PGR▼ Sell$0

We use analytics to understand how market-wall is used. No personal data is sold.